Biotechpharma to expand process development and GMP manufacturing capacity to 5,000 L
18 April 2019 | By Biotechpharma
Biotechpharma UAB will expand its existing manufacturing facility by adding a new line of bioreactors
List view / Grid view
Biopharma
Merck recognised with INTERPHEX Exhibitor Award for Best New Product
10 April 2019 | By Merck
Merck wins award for first-of-its-kind, single-use tangential flow filtration capsule used in ADC and monoclonal antibody bioprocessing...
Merck elevates its BioContinuum platform strategy to deliver ‘ContiGuous’ bioprocessing
4 April 2019 | By Merck
Launch is taking place at the International Pharmaceutical Expo (INTERPHEX) in New York
Paving the way to a bright future for single-use bioprocessing
18 March 2019 | By Swamini Kulkarni
Pharmaceutical and biotech companies together offer life-changing or, more appropriately, life-saving medicines and materials containing medicines for patients across the world. To ensure demand is met and patients’ health is not compromised, it is essential a strong and secure supply chain is in place to support the drug development lifecycle.…
Top novel drug approvals: February 2019
14 March 2019 | By Iqra Farooq
Cablivi and Egaten were the two top novel drugs approved last month, with a focus on parasitic infestation and the rare disorder, aTTP...
Product Hub: Multitron incubation shaker
26 February 2019 | By Infors HT
The Multitron is the number-one choice for reliable, convenient cultivation of microorganisms and cell cultures. The incubation shaker guarantees homogeneous conditions and delivers reproducible results, leaving nothing to be desired regarding its features and capacity.
BPSA releases guide to production of cell and gene therapies
25 February 2019 | By BPSA
The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest whitepaper...
Danaher acquires GE biopharma for $21.4 billion
25 February 2019 | By European Pharmaceutical Review
General Electric is selling its biopharma business for $21.4 billion, with shares in the company jumping 16 percent upon the news...
European Pharmaceutical Review Issue 1 2019
22 February 2019 | By European Pharmaceutical Review
In this issue we look at the challenges of shipping temperature-controlled products, the potential use of blockchain for pharma, and using MALDI-TOF for identification of peptides in suspected illegal medicinal products. The edition also includes articles on aseptic containment, legal advice on licensing negotiations and an In-Depth Focus article from…
Application Note: Sensitive quantitation of the ADC ado-trastuzumab emtansine free cytotoxic drug DM1 in serum using MicroLC-MS
19 February 2019 | By Sciex
Antibody-drug conjugates (ADC’s) are targeted cancer therapeutics that deliver a cytotoxic agent, the payload, to the tumour.
Applying quality risk management to develop an isolator filling line
11 February 2019 | By Particle Measuring Systems
Following the patent of the "Espresso" innovative infusion device, the Italian Biochemical Institute (IBI) "Lorenzini" commissioned Comecer to construct a new isolated filling line.
Pricing dispute over cystic fibrosis drug Orkambi continues in the UK
5 February 2019 | By Nikki Withers (European Pharmaceutical Review)
Campaigners call for UK Government to intervene on pricing dispute over cystic fibrosis drug Orkambi...
Application Note: Highly selective bioanalytical quantitation method for analysis of R and S amlodipine enantiomers in human plasma using LC-MS/MS
5 February 2019 | By Sciex
Amlodipine is an angioselective calcium channel blocker used to treat high blood pressure, chest pain and other conditions caused by coronary artery disease.
Late-stage pipeline drugs could compete with only treatment for SMA
4 February 2019 | By European Pharmaceutical Review
A number of drugs currently in their late stages in the development process could see competition for nusinersen, the only current SMA treatment, rise...
Dr Penny Heaton, Bill & Melinda Gates MRI: ‘Lift while you climb’
29 January 2019 | By Dr Zara Kassam (European Pharmaceutical Review)
As part of EPR’s Women in Pharma series, Dr Penny Heaton, Chief Executive Officer, Bill & Melinda Gates Medical Research Institute, talks to Science Editor Dr Zara Kassam about the need to disrupt global health product development by applying cutting-edge science and technology to combat age-old diseases in the world’s…
Follow: